The latest research on long COVID symptoms, treatments & more with Andrea Garcia, JD, MPH

AMA's Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, discusses the latest research on long COVID, as well as #omicron variant XBB.1.5 and other #SARSCoV2 subvariants. Also covering how the Biden Administration's decision to end COVID-19 national emergency and U.S. public health emergency on May 11 will affect hospitals, physicians and patients—while the World Health Organization (WHO) maintains the COVID-19 pandemic is still a global health emergency. American Medical Association CXO Todd Unger hosts.

Watch, read, or listen to Sandra Fryhofer, MD, AMA Board Chair's recent #vaccine and bivalent booster episode, here: https://www.ama-assn.org/delivering-care/public-health/bivalent-vaccine-effectiveness-covid-booster-schedule-and-evusheld

00:00 #AMA Update for Feb. 1, 2023
00:32 Biden Administration to end #COVID19 emergency declarations on May 11
01:53 What's driving the White House's decision?
03:21 What does this mean for hospitals, physicians and patients?
03:36 How much will #COVID vaccines cost?
04:14 Are COVID tests still free?
04:32 COVID treatment costs in the US
05:25 COVID cases in the U.S.
05:38 COVID-19 hospitalizations and deaths
05:53 XBB 1.5 variant
07:17 Effective COVID treatments: Paxlovid, Lagevrio, Veklury and more
08:02 Contact ASPR at [email protected] with questions
08:38 New data from long COVID study
09:55 Long COVID symptoms
10:37 Women are worst affected by long COVID, study finds
11:10 #coronavirus still considered global health emergency by #WHO

Visit the AMA Update video page for more videos in this series: https://www.ama-assn.org/ama-update-videos.
Be the first to comment